SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902595-09-000044
Filing Date
2009-06-24
Accepted
2009-06-24 16:42:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 IDM PHARMA, INC. SCHEDULE 13D-AMENDMENT NO. 3 idm-amendno3.htm SC 13D/A 276135
  Complete submission text file 0000902595-09-000044.txt   278152
Mailing Address 9 PARKER, SUITE 100 IRVINE CA 92618-1605
Business Address 9 PARKER, SUITE 100 IRVINE CA 92618-1605 949-470-4751
IDM PHARMA, INC. (Subject) CIK: 0000822206 (see all company filings)

IRS No.: 330245076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46179 | Film No.: 09907752
SIC: 2834 Pharmaceutical Preparations

Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors, LLC (Filed by) CIK: 0001306923 (see all company filings)

IRS No.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A